These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 27429592

  • 1. Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression.
    Lau HK, Hsieh MJ, Yang SF, Wang HL, Kuo WH, Lee HL, Yeh CB.
    Int J Med Sci; 2016; 13(7):556-61. PubMed ID: 27429592
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection.
    Bakr NM, Awad A, A Moustafa E.
    IUBMB Life; 2018 Feb; 70(2):165-174. PubMed ID: 29341496
    [Abstract] [Full Text] [Related]

  • 4. Association of interleukin-18 genotypes (-607C > A) and (-137 G > C) with the hepatitis B virus disease progression to hepatocellular carcinoma.
    Ali T, Saxena R, Rani I, Sharma R, More D, Ola R, Agarwal S, Chawla YK, Kaur J.
    Mol Cell Biochem; 2021 Nov; 476(11):3923-3933. PubMed ID: 34165682
    [Abstract] [Full Text] [Related]

  • 5. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
    Zhang QX, Li SL, Yao YQ, Li TJ.
    Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM, Hetta HF, Koneru G, Ammar M, Shafik EA, Mohareb DA, Abbas El-Masry M, Ramadan HK, Abu Rahma MZ, Fawzy MA, Fathy M.
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
    Liu S, Qiu XQ, Zeng XY, Bai H, Bei CH, Yang Y.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of interleukin-18 polymorphisms -607A/C and -137G/C on oral cancer occurrence and clinical progression.
    Tsai HT, Hsin CH, Hsieh YH, Tang CH, Yang SF, Lin CW, Chen MK.
    PLoS One; 2013 Jun; 8(12):e83572. PubMed ID: 24349532
    [Abstract] [Full Text] [Related]

  • 14. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
    Jiao X, Luo Y, Yang B, Jing L, Li Y, Liu C, Jing X, Wang F, Wang Y, Du Z, Gao Y.
    Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
    Liu F, Li F, Luo L, Yang H, Wei Y, Wang W, Yan L, Wen T, Yang J, Li B.
    Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.